Skip to main content
Log in

Malpractice liability, technology choice and negative defensive medicine

  • Original Paper
  • Published:
The European Journal of Health Economics Aims and scope Submit manuscript

Abstract

We extend the theoretical literature on the impact of malpractice liability by allowing for two treatment technologies, a safe and a risky one. The safe technology bears no failure risk, but leads to patient-specific disutility since it cannot completely solve the health problems. By contrast, the risky technology (for instance a surgery) may entirely cure patients, but fail with some probability depending on the hospital’s care level. Tight malpractice liability increases care levels if the risky technology is chosen at all, but also leads to excessively high incentives for avoiding the liability exposure by adopting the safe technology. We refer to this distortion toward the safe technology as negative defensive medicine. Taking the problem of negative defensive medicine seriously, the second best optimal liability needs to balance between the over-incentive for the safe technology in case of tough liability and the incentive to adopt little care for the risky technology in case of weak liability. In a model with errors in court, we find that gross negligence where hospitals are held liable only for very low care levels outperforms standard negligence, even though standard negligence would implement the first best efficient care level.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Notes

  1. See e.g. the famous Harvard-study [33] and the comment by Hyman [19].

  2. See e.g. Boehm [3] for suggestions in this direction.

  3. See e.g. Kessler and McClellan [25].

  4. See e.g. Localio et al. [31] and Dubay et al. [12].

  5. The problem could only have been solved by signing a complete contract, which is obviously impossible in our context, though. Consequently, Arlen and McLeod [1] use an incomplete contract approach to analyze malpractice liability.

  6. See e.g. Cohen and Eisenberg [5] for a discussion of high liability risks in these cases.

  7. By slight abuse of terminology, we subsequently use “treatment” and “technology” synonymously.

  8. See our literature review below.

  9. “Care” does not necessarily refer to a doctor’s effort during a surgery, for instance, but also to the organization of processes in the hospital. In fact, Rogers et al. [35] find in a case study of 444 malpractice claims that communication breakdowns were responsible in around one quarter of all observations. They point out that malpractice claims should be used much more intensively as information sources in finding out where malpractice comes from; see also Studdert et al. [40, p. 287].

  10. For instance, the Hospital Quality Alliance (HQA) in the US has designed pay-for-performance programs by defining best practice based on individual and composite measures for heart failure, acute myocardial infarction and pneumonia, and there is econometric evidence that hospitals taking part in the program have higher quality improvements; see e.g. Lindenauer et al. [30] and Werner et al. [43]. The authors admit that controlling for self-selection issues is difficult, though.

  11. See e.g. Kessler et al. [27, p. 2619] for a brief overview on factors influencing expected damages for malpractice.

  12. See e.g. Boumil et al. [4].

  13. See e.g. Faure and Koziol [14] and Kennedy and Grubb [22].

  14. See e.g. National Practitioner Data Bank (NPDB) [34], and U.S. Department of Health and Human Services [42].

  15. For an earlier comprehensive overview on the theoretical and empirical literature see Danzon [9], and for an assessment of the situation from a legal point of view see Hyman and Silver [20].

  16. We are grateful to an anonymous referee who has pointed to this artifact of the discrete modeling that we used in a former working paper version of this article.

  17. Assuming that the patient’s disutility from the safe technology is independent of the hospital’s care level normalized to zero is without loss of generality. All we need is that the patient’s health reacts more sensitively to the hospital’s care under the risky technology. As mentioned in the introduction, it is not crucial for our results that the hospital can perfectly observe the patient’s disutility θ; all that is required is an informative signal.

  18. See our discussion in the concluding section.

  19. One might wonder if non-liability costs should be part of the social cost function as part of these costs may be purely re-distributional. This will be discussed in the concluding section. Our results are qualitatively independent of whether α enters the social cost function or not, though.

  20. As usual in the literature on liability, “costs” include both monetary terms such as treatment expenditures (x in our case) and the monetary equivalents of preference costs from the patient’s harm or from the doctors’ empathy for patients (1 + α in our case).

  21. For x < q, the uniform distribution causes the artifact that courts could receive signals on negative care, τ < 0. This can easily be avoided by assuming instead that the probability mass is centered on zero which yields identical results.

  22. Implicitly, we hence assume that proving causation is no issue. See our discussion in the concluding section.

  23. As usual, gross negligence is defined as a negligence standard below ordinary negligence, i.e. as a rule where liability is only confirmed for very low care levels.

  24. These similarities and differences of causation standards and negligence standards in a general model with asymmetric information have recently been analyzed by Feess et al. [17].

References

  1. Arlen, J., Mac Leod, W.B.: Malpractice liability for physicians and managed care organizations. N. Y. Univ. Law Rev. 78(6), 1929–2006 (2003)

    Google Scholar 

  2. Baicker, K., Chandra, A.: The effect of malpractice liability on the delivery of health care. Forum. Health Econ. Policy 8(4), (2005)

  3. Boehm, G.: Debunking medical malpractice myths: unraveling the false premises behind “tort reform”. Yale J. Health Policy Law Ethics 5(1), 357–369 (2005)

    PubMed  Google Scholar 

  4. Boumil, M., Elias, C., Moes, D.: Medical Liability in a Nutshell. Thomson West, St. Paul (2003)

    Google Scholar 

  5. Cohen, M.H., Eisenberg, D.: Potential physician malpractice liability associated with complementary and integrative medical therapies. Ann. Intern. Med. 136(8), 596–603 (2002)

    PubMed  Google Scholar 

  6. Craswell, R., Calfee, J.: Deterrence and uncertain legal standards. J. Law Econ. Organiz. 2(2), 279–303 (1986)

    Google Scholar 

  7. Danzon, P.: Liability and liability insurance for medical malpractice. J. Health Econ. 4, 309–331 (1985)

    Article  PubMed  CAS  Google Scholar 

  8. Danzon, P.: Alternative liability regimes for medical injuries: evidence from simulation analysis. J. Risk Insur. 61(2), 219–244 (1994)

    Article  Google Scholar 

  9. Danzon, P.: Liability for medical malpractice. In: Culyer, A.J., Newhouse, J.P. (eds) Handbooks in Economics, vol. 17. Handbook of Health Economics, pp. 1339–1404. Elsevier, Amsterdam (2000)

    Google Scholar 

  10. Demougin, D., Fluet, C.: Preponderance of the evidence. Eur. Econ. Rev. 50(2), 963–976 (2005)

    Google Scholar 

  11. Diamond, P.: Single activity accidents. J. Legal Stud. 3, 107–164 (1974)

    Article  Google Scholar 

  12. Dubay, L., Kaestner, R., Waidmann, T.: The impact of malpractice fears on cesarean section rates. J. Health Econ. 18, 491–522 (1999)

    Article  PubMed  CAS  Google Scholar 

  13. Ewert, R.: Auditor liability and the precision of auditing standards. J. Inst. Theor. Econ. 155, 181–206 (1999)

    Google Scholar 

  14. Faure, M., Koziol, H.: Cases on Medical Malpractice in a Comparative Perspective, Tort and Insurance Law. Springer, Berlin (2001)

    Book  Google Scholar 

  15. Feess, E., Ossig, S.: Reimbursement schemes for hospitals, malpractice liability, and intrinsic motivation. Int. Rev. Law Econ. 27(4), 423–441 (2007)

    Article  Google Scholar 

  16. Feess, E., Muehlheusser, G., Wohlschlegel, A.: Environmental liability under uncertain causation. Eur. J. Law Econ. 28(2), 133–148 (2009a)

    Article  Google Scholar 

  17. Feess, E., Muehlheusser, G., Wohlschlegel, A.: Screening in courts: on the joint use of negligence and causation standards. J. Law Econ. Organiz. (forthcoming) (2009b)

  18. Gal-Or, E.: Optimal reimbursement and malpractice sharing rules in health care markets. J. Regul. Econ. 16, 237–265 (1999)

    Article  Google Scholar 

  19. Hyman, D.A.: Medical malpractice: what do we know and what (if anything) should we do about it? Texas Law Rev. (June 1), 1639–1655 (2002)

  20. Hyman, D.A., Silver, C.: The poor state of health care quality in the U.S.: is malpractice liability part of the problem or part of the solution?. Cornell Law Rev. 90(4), 893–993 (2005)

    PubMed  Google Scholar 

  21. Katz, D.A., Williams, G.C., Brown, R.L., Aufderheide, T.P., Bogner, M., Rahko, P.S. et al.: Emergency physicians’ fear of malpractice in evaluating patients with possible acute cardiac ischemia. Ann. Emerg. Med. 46(6) (2005)

  22. Kennedy, I., Grubb, A.: Medical Law, 3rd edn. Butterworths, London (2000)

    Google Scholar 

  23. Kessler, D.P., McClellan, M.B.: Do doctors practice defensive medicine. Q. J. Econ. 111, 353–390 (1996)

    Article  Google Scholar 

  24. Kessler, D.P., McClellan, M.B.: The effects of malpractice pressure and liability reforms on physicians’ perceptions of medical care. Law Contemp. Probl. 60, 81–106 (1997)

    Article  Google Scholar 

  25. Kessler, D.P., McClellan, M.B.: How liability law affects medical productivity. J. Health Econ. 21, 931–955 (2002)

    Article  PubMed  Google Scholar 

  26. Kessler, D.P., McClellan, M.B.: Malpractice law and health care reform: optimal liability policy in an era of managed care. J. Public Econ. 84, 175–197 (2002)

    Article  Google Scholar 

  27. Kessler, D.P., Sage, W.M., Becker, D.J.: Impact of malpractice reforms on the supply of physician services. J. Am. Med. Assoc. 293(21), 2618–2625 (2005)

    Article  CAS  Google Scholar 

  28. Kessler, D.P., Summerton, N., Graham, J.R.: Effects of the medical liability system in Australia, the UK, and the USA. Lancet 368, 240–246 (2006)

    Article  PubMed  Google Scholar 

  29. Kolstad, C.D., Ulen, T.S., Johnson, G.V.: Ex post liabiliy for harm vs. ex ante safety regulation: substitutes or complements. Am. Econ. Rev. 80(4), 888–901 (1990)

    Google Scholar 

  30. Lindenauer, P.K., Remus, D., Roman, S., Rothberg, M.B., Benjamin, E.M., Ma, A. et al.: Public reporting and pay for performance in hospital quality improvement. N. Engl. J.Med. 356(5), 486–496 (2007)

    Article  PubMed  CAS  Google Scholar 

  31. Localio, A.R., Lawthers, A.G., Bengtson, J.M., Hebert, L.E., Weaver, S.L., Brennan, T.A. et al.: Relationship between malpractice claims and cesarean delivery. J. Am. Med. Assoc. 269(3), 366–373 (1993)

    Article  CAS  Google Scholar 

  32. Luce, J.M.: Medical malpractice and the chest physician. CHEST 134, 1044–1050 (2008)

    Article  PubMed  Google Scholar 

  33. Mello, M.M., Brennan, T.A.: Deterrence of medical errors: theory and evidence for malpractice reform. Tex. Law Rev. 80, 1595–1637 (2002)

    Google Scholar 

  34. National Practitioner Data Bank Annual Report (NPDB) (ed.): U.S. Department of Health and Human Services, Health Resources and Services Administration (2002)

  35. Rogers, S.O., Gawande, A.A., Kwaan, M., Puopolo, A.L., Yoon, C., Brennan, T.A. et al.: Analysis of surgical errors in closed malpractice claims at 4 liability insurers. Surgery 140(1), 25–33 (2006)

    Article  PubMed  Google Scholar 

  36. Schwartz, R.: Auditors’ liability, vague due care and auditing standards. Rev. Quant. Finance Account. 11, 183–207 (1998)

    Article  Google Scholar 

  37. Shavell, S.: Foundations of Economic Analysis of Law. Harvard University Press, Boston (2004)

    Google Scholar 

  38. Sobel, D.L., Loughlin, K.R., Coogan, C.L.: Medical malpractice liability in clinical urology: a survey of practicing urologists. J. Urol. 175, 1847–1851 (2006)

    Article  PubMed  Google Scholar 

  39. Studdert, D.M., Mello, M.M., Brennan, T.A.: Medical malpractice. N. Engl. J. Med. 350(3), 283–292 (2004)

    Article  PubMed  CAS  Google Scholar 

  40. Studdert, D.M., Mello, M.M., Gawande, A.A., Gandhi, T.K., Kachalia, A., Catherine Yoon, C. et al.: Claims, errors, and compensation payments in medical malpractice litigation. N. Engl. J. Med. 354(19), 2024–2033 (2006)

    Article  PubMed  CAS  Google Scholar 

  41. Studdert, D.M., Mello, M.M., Sage, W.M., DesRoches, C.M., Peugh, J., Zapert, K. et al.: Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. J. Am. Med. Assoc. 293(21), 2609–2617 (2005)

    Article  CAS  Google Scholar 

  42. U.S. Department of Health and Human Services (ed.): Confronting the new health care crisis: improving health care quality and lowering costs by fixing our medical liability system (2002)

  43. Werner, R.M., Goldman, L.E., Dudley, R.A.: Comparisons of change in quality of care between safety-net and non-safety-net hospitals. J. Am. Med. Assoc. 299(18), 1–16 (2008)

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eberhard Feess.

Appendix

Appendix

Proof of the first best benchmark

part (ii). \(\frac{\partial \widetilde{\theta }}{{\rm d}\alpha }\) can be written as

$$ \frac{\partial \widetilde{\theta }}{{\rm d}\alpha }=\frac{\frac{\partial x}{ \partial \alpha }\left( 1+\alpha \right) \left[ p^{\prime }\left( x\right) \left( 1+\alpha \right) +1\right] -x}{\left( 1+\alpha \right) ^{2}}<0 $$
(14)

since \(\left[ p^{\prime }\left( x\right) \left( 1+\alpha \right) +1\right] =0 \) as this is the first order condition for the optimal care level expressed by Eq. 3. □

Proof of Proposition 2

Part (i). Applying the implicit function theorem to the hospital’s first order condition

$$ A\equiv \left[ p^{\prime }\left( x\right) d\left( x,\widehat{x},q\right) +p\left( x\right) \frac{\partial d\left( x,\widehat{x},q\right) }{\partial x}\right] +p^{\prime }\left( x\right) \alpha +1=0 $$
(15)

yields

$$ \frac{{\rm d}x^{\ast }}{{\rm d}\widehat{x}}=-\frac{p^{\prime }\left( x\right) \frac{ \partial {\rm d}(\cdot )}{\partial \widehat{x}}+p\left( x\right) \frac{\partial ^{2}{\rm d}(\cdot )}{\partial x\partial \widehat{x}}}{\frac{\partial ^{2}A\left( \cdot \right) }{\partial x^{2}}}>0 $$
(16)

since \(p^{\prime }\left( x\right) <0\), \(\frac{\partial {\rm d}(\cdot )} {\partial \widehat{x}}=\frac{1}{2q}>0\), \(\frac{\partial ^{2}{\rm d}(\cdot )}{\partial x\partial \widehat{x}}=0\), and because \(\frac{\partial ^{2}A}{\partial x^{2}}>0\) is required for an interior solution for the hospital’s care level. Part (ii). Applying again the implicit function theorem, and making use of \(\frac{\partial {\rm d}(\cdot )}{\partial q}=-\frac{\left( \widehat{x}-x\right) }{2q^{2}}\) and \(\frac{\partial ^{2}{\rm d}(\cdot )}{\partial x\partial q}=\frac{1}{2q^{2}}\), we get

$$ \frac{\partial x^{\ast }}{\partial q}=-\frac{-p^{\prime }\left( x\right) \frac{\left( \widehat{x}-x\right) }{2q^{2}}+p\left( x\right) \frac{1}{2q^{2}} }{\frac{\partial ^{2}A\left( \cdot \right) } {\partial x^{2}}}=\frac{ p^{\prime }\left( x\right) \left( \widehat{x}-x\right) -p\left( x\right) }{ 2q^{2}\cdot \frac{\partial ^{2}A\left( \cdot \right) }{\partial x^{2}}}, $$
(17)

so that the sign depends on \(Z\equiv \left( \widehat{x}-x\right) p^{\prime }(x)+p(x)\). If \(x<\widehat{x}\), then Z < 0 due to \(p^{\prime }\left( x\right) <0\), and hence \(\frac{\partial x^{\ast }(\cdot )}{\partial q}<0\). For \(x\geq \widehat{x}\) we get \(\frac{\partial x^{\ast }(\cdot )}{\partial q}<0\) if and only if \(-\frac{p(x)}{p^{\prime }(x)}<\left( x-\widehat{x}\right) \). Part (iii). We prove by contradiction. Define x *1 (x *2 ) as the cost minimizing care levels for \(\widehat{x}_{1}\) (\(\widehat{x}_{2}\)), and assume \(\widehat{x}_{2}<\widehat{x}_{1}\). Now suppose that, for \(\widehat{x}_{2}\), the hospital does not choose x *2 but x *1 . Then,

$$ \begin{aligned} &C\left( x_{1}^{\ast },\widehat{x}_{2},q\right) -C\left( x_{1}^{\ast }, \widehat{x}_{1},q\right)\\ &\quad =\left[ p\left( x_{1}^{\ast }\right) d\left( x_{1}^{\ast },\widehat{x} _{2},q\right) +p\left( x_{1}^{\ast }\right) \alpha +x_{1}^{\ast }\right] - \left[ p\left( x_{1}^{\ast }\right) d\left( x_{1}^{\ast },\widehat{x} _{1},q\right) +p\left( x_{1}^{\ast }\right) \alpha +x_{1}^{\ast }\right] \\ &\quad =p\left( x_{1}^{\ast }\right) \left[ d\left( x_{1}^{\ast },\widehat{x} _{2},q\right) -d\left( x_{1}^{\ast },\widehat{x}_{1},q\right) \right] <0 \\ \end{aligned} $$
(18)

as \(\frac{\partial d\left( x,\widehat{x},q\right) }{\partial \widehat{x}}>0\). Furthermore, \(C\left( x_{2}^{\ast },\widehat{x}_{2},q\right) -C\left( x_{1}^{\ast },\widehat{x}_{2},q\right) <0\) by definition of the optimality of x *2 . Combining the two inequalities yields \(C\left( x_{2}^{\ast },\widehat{x}_{2},q\right) -C\left( x_{1}^{\ast },\widehat{x}_{1},q\right) <0\), and thus \(\frac{\partial C\left( x^{\ast },\widehat{x},q\right) }{\partial \widehat{x}}>0\). Part (iv). The hospital chooses the risky technology if

$$ p\left( x^{\ast }\right) d\left( x^{\ast },\widehat{x},q\right) +p\left( x^{\ast }\right) \alpha +x^{\ast }\leq \alpha \theta, $$
(19)

which yields a threshold of

$$ \widetilde{\theta }^{N}=\frac{p\left( x^{\ast }\right) d\left( x^{\ast }, \widehat{x},q\right) +p\left( x^{\ast }\right) \alpha +x^{\ast }}{\alpha }. $$
(20)

Note that we need to compare to the optimal threshold under the assumption that \(x^{\ast }\left( \widehat{x},q\right) \) is chosen as this is the relevant case given that a negligence rule is in place. Thus, the relevant second best optimal threshold is \(\widetilde{\theta }^{S}=\frac{p\left( x^{\ast }\right) \left( 1+\alpha \right) +x^{\ast }}{1+\alpha }\), and not \(\widetilde{\theta }^{f}\) (using \(\widetilde{\theta }^{f}\) would only reinforce the result, though). Comparing these two thresholds gives

$$ \begin{aligned} \Updelta \widetilde{\theta }^{N} \equiv &\widetilde{\theta }^{N}-\widetilde{ \theta }^{S}= \frac{p\left( x^{\ast }\right) d\left( x^{\ast },\widehat{x} ,q\right) +p\left( x^{\ast }\right) \alpha +x^{\ast }}{\alpha }-\frac{ p\left( x^{\ast }\right) \left( 1+\alpha \right) +x^{\ast }}{1+\alpha}\\ =&\frac{\left[ x^{\ast }+d\left( x^{\ast },\widehat{x},q\right) p\left( x^{\ast }\right) \right] \left( 1+\alpha \right) }{\alpha \left( 1+\alpha \right)}>0. \end{aligned} $$
(21)

Proof of Proposition 3

For \(\widehat{x}=0\), we have \(x^{\ast }\left( \widehat{x},q\right) =0\) as \(d\left( x^{\ast },\widehat{x},q\right) =0\quad\forall x\), and since \(\frac{\partial C\left( \cdot \right) }{\partial x}>0\quad\forall x\) if \({\rm d}\left( \cdot \right) =0\). Furthermore, we know from part (i) of Proposition 2 that \(\frac{\partial x^{\ast }}{\partial \widehat{x}}>0\) as long as \({\rm d}\left( \cdot \right) \in \left[ 0,1\right] \). And if \({\rm d}\left( \cdot \right) =1\), then we are back to strict liability where we know from Proposition 1 that \(x^{\ast }=x^{f}\). □

Proof of Proposition 4

Suppose that, with negligence, the regulator sets \(\widehat{x}^{N}\), i.e. the due care level that implements the first best care level x f. As the care level is then the same with strict liability and with negligence, the welfare ranking depends only on the incentive to adopt the risky technology. Furthermore, we know from Proposition 1 and Proposition 2, part (iv), respectively, that this incentive is too small under both liability rules. Hence, the lower \(\widetilde{\theta }\), the better. Comparing the hospital’s costs with negligence and with strict liability for \(\widehat{x}^{N}\) gives

$$ \begin{aligned} \Updelta C &\equiv C^{N}\left( x^{f},\widehat{x}^{N}\right) -C^{\rm SL}\\ &=p\left( x^{f}\right) d\left( x^{f},\widehat{x},q\right) +p\left( x^{f}\right) \alpha +x^{f}-\left( p\left( x^{f}\right) \left( 1+\alpha \right) +x^{f}\right)\\ &=-p\left( x^{f}\right) \left[ 1-d\left( x^{f},\widehat{x},q\right) \right] <0 \\ \end{aligned} $$
(22)

which proves that \(\widetilde{\theta }^{N}\left( \widehat{x}^{N}\right) <\widetilde{\theta }^{\rm SL}\) and thus \(SC\left( \widehat{x}^{N}\right) <SC^{\rm SL}\). Finally, it follows by definition of optimality that social costs with the second best optimal due care level \(\widehat{x}^{S}\) are weakly below those with \(\widehat{x}^{N}\), hence

$$ C^{N}\left( x^{\ast },\widehat{x}^{S}\right) \leq C^{N}\left( x^{f},\widehat{ x}^{N}\right) <C^{\rm SL}.$$
(23)

Proof of Proposition 5

Social costs are

$$ SC=\int\limits_{0}^{\widetilde{\theta }(\widehat{x})}\left( 1+\alpha \right) \theta f(\theta ){\rm d}\theta +\int\limits_{\widetilde{\theta }(\widehat{x})}^{1}\left[ \left( 1+\alpha \right) p\left( x\left( \widehat{x}\right) \right) +x\left( \widehat{x}\right) \right] f(\theta ){\rm d}\theta . $$
(24)

All patients with \(\theta \leq \widetilde{\theta }(\widehat{x})\) are treated with the safe technology, and social costs are then \(\left( 1+\alpha \right) \theta \) for patient type θ. All other patients are treated with the risky technology, and social costs for each patient are then given by the term in angled brackets. Taking the derivative with respect to the due care level \(\widehat{x}\) yields

$$ \begin{aligned} \frac{\partial \left( SC\right) }{\partial \widehat{x}}&=A+B+C=\frac{ \partial \widetilde{\theta }(\widehat{x})}{\partial \widehat{x}} \left( 1+\alpha \right) \widetilde{\theta }(\widehat{x})f(\widetilde{\theta }( \widehat{x})) -\frac{\partial \widetilde{\theta }(\widehat{x})}{\partial \widehat{x}}\left( 1+\alpha \right) p\left( x\left( \widehat{x}\right) \right) f(\widetilde{\theta }(\widehat{x})) \\ &\quad +\int\limits_{\widetilde{\theta }(\widehat{x})}^{1}\left[ \frac{\partial x\left( \widehat{x}\right) }{\partial \widehat{x}}\left( \left( 1+\alpha \right) p^{\prime }+1\right) \right] f(\theta ){\rm d}\theta . \end{aligned} $$
(25)

We now prove by inspection. The first part (A) is positive due to \(\frac{\partial \widetilde{\theta }(\widehat{x})}{\partial \widehat{x}}>0\) and expresses that social costs are increasing in \(\widehat{x}\) as more patients are then treated with the safe technology. Again due to \(\frac{\partial \widetilde{\theta }(\widehat{x})}{\partial \widehat{x}}>0\), the second part (B) is negative and captures the benefit from the fact that fewer patients are treated with the risky technology. Finally, the third part (C) expresses the marginal social costs for patients treated with the risky technology, and will hence be zero at x = x f.

We already know from Proposition 2, part (iv), that, at x = x f, too many patients are treated with the risky technology which is identical to saying that A >  −B. Since C = 0 at x f, this implies that \(\frac{\partial \left( SC\right) }{\partial \widehat{x}}>0\) at \(\widehat{x}^{N}\) (recall that \(x^{\ast }\left( \widehat{x}^{N}\right) =x^{f}\) by definition of \(\widehat{x}^{N}\)). Hence, \(\widehat{x}\) must be reduced. This reduces \(\widetilde{\theta }(\widehat{x})\), and hence the first part (A). Furthermore, note that the third part is then negative (C < 0) since \(-p^{\prime }\left( \widehat{x}^{S}\right) >-p^{\prime }\left(\widehat{x}^{N}\right) \) for \(\widehat{x}^{S}<\widehat{x}^{N}\) due to \(p^{\prime \prime }(x)>0\). □

Rights and permissions

Reprints and permissions

About this article

Cite this article

Feess, E. Malpractice liability, technology choice and negative defensive medicine. Eur J Health Econ 13, 157–167 (2012). https://doi.org/10.1007/s10198-010-0294-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10198-010-0294-7

Keywords

JEL Classification

Navigation